Theravance Biopharma Inc. (TBPH)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1. 7,457,060 $83,817,354 4%
2. 7,012,226 $78,817,420 11.12%
3.
Irenic Capital Management

Adam Katz And Andy Dodge

2,760,948 $31,033,056 6.15%
4.
Newtyn Management

Noah Levy And Eugene Dozortsev

1,900,000 $21,356,000 +4% 4.19%
5.
Oasis Management

Seth Fischer

1,006,858 $11,317,084 +6% 2.08%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$22.54 1,000 Director 56,757 2018-05-21 Filing
$26.34 4,000 Officer 213,180 2017-08-21 Filing
$24.69 4,000 Director 4,000 2017-08-11 Filing
$24.59 15,000 Director 15,000 2017-08-11 Filing
$24.59 15,000 Director 47,571 2017-08-11 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$8.71 1,254 311,733 2024-02-22 Filing
$10.29 1,378 331,206 2023-11-21 Filing
$10.22 2,482 346,839 2023-11-14 Filing
$9.03 2,482 334,321 2023-10-16 Filing
$9.89 2,482 336,803 2023-09-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 4,587,834 $51,567,256 0%
2. 3,489,262 $39,219,305 0%
3. 2,168,397 $24,372,782 0.02%
4. 1,390,314 $15,627,129 0%
5. 994,000 $11,173,535 0%
News See All